Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_assertion type Assertion NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_head.
- NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_assertion wasGeneratedBy ECO_0000203 NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_provenance.
- NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_assertion wasDerivedFrom befree-20150227 NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_provenance.
- NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_assertion SIO_000772 9679568 NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_provenance.
- NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_assertion evidence source_evidence_literature NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_provenance.
- NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_assertion description "[Phase 1 clinical evaluation of oltipraz has demonstrated its ability to induce GST activity as well as the level of transcripts encoding gamma-glutamylcysteine synthetase (gamma-GCS) and DT-diaphorase in the colon mucosa of individuals at increased risk for colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427733.RABTeQtHcW7xr7LRA1RmwEV0pvNwpky1GCBGC36czkC88130_provenance.